{"id":10139,"date":"2016-10-13T07:42:25","date_gmt":"2016-10-13T07:42:25","guid":{"rendered":"http:\/\/wames.org.uk\/cms-english\/?p=10139"},"modified":"2016-10-13T07:42:25","modified_gmt":"2016-10-13T07:42:25","slug":"possible-clinical-diagnostic-tool-for-cfs-based-on-the-ratios-of-metabolites-in-blood-plasma","status":"publish","type":"post","link":"https:\/\/wames.org.uk\/cms-english\/possible-clinical-diagnostic-tool-for-cfs-based-on-the-ratios-of-metabolites-in-blood-plasma\/","title":{"rendered":"Possible clinical diagnostic tool for CFS based on the ratios of metabolites in blood plasma"},"content":{"rendered":"<h3>Research abstract:<\/h3>\n<p>Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with\/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood.<\/p>\n<p>Here, we performed comprehensive <a href=\"https:\/\/en.wikipedia.org\/wiki\/Metabolomics\" target=\"_blank\">metabolomic analyses <\/a>of 133 <a href=\"https:\/\/en.wikipedia.org\/wiki\/Blood_plasma\" target=\"_blank\">plasma<\/a> samples obtained from CFS patients and healthy controls to establish an objective diagnosis of CFS. CFS patients exhibited significant differences in intermediate metabolite concentrations in the <a href=\"https:\/\/www.britannica.com\/science\/tricarboxylic-acid-cycle\" target=\"_blank\">tricarboxylic acid <\/a>(TCA) and <a href=\"https:\/\/en.wikipedia.org\/wiki\/Urea_cycle\" target=\"_blank\">urea cycles<\/a>.<\/p>\n<p>The combination of ornithine\/citrulline and pyruvate\/isocitrate ratios discriminated CFS patients from healthy controls, yielding area under the receiver operating characteristic curve values of 0.801 (95% confidential interval [CI]: 0.711\u20130.890,\u00a0P\u2009&lt;\u20090.0001) and 0.750 (95% CI: 0.584\u20130.916,\u00a0P\u2009=\u20090.0069) for training (n\u2009=\u200993) and validation (n\u2009=\u200940) datasets, respectively. These findings provide compelling evidence that a clinical diagnostic tool could be developed for CFS based on the ratios of metabolites in plasma.<\/p>\n<p><a href=\"http:\/\/www.nature.com\/articles\/srep34990\" target=\"_blank\">Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles<\/a>, by Emi Yamano,\u00a0Masahiro Sugimoto,\u00a0Akiyoshi Hirayama,\u00a0Satoshi Kume ,\u00a0Masanori Yamato,\u00a0Guanghua Jin,\u00a0Seiki Tajima,\u00a0Nobuhito Goda,\u00a0Kazuhiro Iwai,\u00a0Sanae Fukuda,\u00a0Kouzi Yamaguti,\u00a0Hirohiko Kuratsune, Tomoyoshi Soga,\u00a0Yasuyoshi Watanabe &amp;\u00a0Yosky Kataoka <span style=\"text-decoration: underline;\">in<\/span><br \/>\n<em>Scientific Reports<\/em>\u00a06, Article\u00a0number:\u00a034990 (2016) [Published online: 11 October 2016]<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Research abstract: Chronic fatigue syndrome (CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with\/without infectious or neuropsychiatric symptoms, lasting at least 6 consecutive months. Its pathogenesis remains incompletely understood. Here, we performed comprehensive &hellip; <a href=\"https:\/\/wames.org.uk\/cms-english\/possible-clinical-diagnostic-tool-for-cfs-based-on-the-ratios-of-metabolites-in-blood-plasma\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[726,1327,3170,3171,759,3169],"class_list":["post-10139","post","type-post","status-publish","format-standard","hentry","category-news","tag-biomarkers","tag-metabolites","tag-tricarboxylic-acid-cycle","tag-urea-cycle","tag-yasuyoshi-watanabe","tag-yosky-kataoka"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5qkYK-2Dx","_links":{"self":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/10139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/comments?post=10139"}],"version-history":[{"count":3,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/10139\/revisions"}],"predecessor-version":[{"id":10151,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/10139\/revisions\/10151"}],"wp:attachment":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/media?parent=10139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/categories?post=10139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/tags?post=10139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}